Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Light Sciences Adipose was a biotechnology company focused on the development of non-invasive treatments for fat reduction and body contouring. As a subsidiary of Light Sciences Corporation, the company leveraged the proprietary LitX (Light Infused Therapy) platform, which utilized light-emitting diodes (LEDs) to target and disrupt subcutaneous adipose tissue. The technology was designed to induce adipocyte apoptosis, providing a less invasive alternative to surgical procedures like liposuction. Although the company reached the clinical testing stage, it is no longer active following the dissolution or restructuring of its parent organization's various divisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Light Sciences Adipose.